Wednesday, 14 October 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 10, 2025

Strive Announces Nasdaq Listing of SATA and Closing of Oversubscribed & Upsized IPO

View original at globenewswire.com
Strive Announces Nasdaq Listing of SATA and Closing of Oversubscribed & Upsized IPO Strive has acquired 1,567 Bitcoin at an average price of $103,315 and holds 7,525 Bitcoin as of November 10, 2025.The company expects the dividends for SATA to be return of capital (ROC) dividends, enhancing its after-tax yield potentia…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • By introducing a variable-rate dividend security initially set at 12% and payable monthly when declared, Strive is providing investors with an attractive yield opportunity

    80% confidence
  • Strive is focused on increasing Bitcoin per share to outperform Bitcoin over the long run

    80% confidence
  • The successful IPO of the SATA Stock makes Strive the first Bitcoin treasury company to finance its Bitcoin amplification exclusively through perpetual preferred equity, and the second overall, after Strategy, to issue a publicly traded perpetual preferred equity security

    80% confidence
  • Strive has quickly shown the market both the speed and the precision the team operates with to drive long-term value to shareholders, with Bitcoin as the hurdle rate

    80% confidence
  • The company expects the dividends for SATA to be return of capital (ROC) dividends, enhancing its after-tax yield potential

    80% confidence
  • Strive intends to actively manage the dividend and issuance rate with the goal of maintaining SATA Stock's trading price within its stated long-term range of $95 and $105 per share

    80% confidence
  • Bitcoin's maturation as a scarce, liquid, and transparent asset makes it an incredible foundation for a disciplined long duration risk conscious yield instrument

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com
Strive Announces Nasdaq Listing of SATA and Closing of Oversubscribed & Upsized IPO — Source | Via News | ViaNews EU